Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection.
Hematol Oncol
; 41(5): 904-911, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37452579
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ritonavir
/
COVID-19
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Hematol Oncol
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: